TADAWUL:4016 Revenue

Middle East Pharmaceutical Industries Company had revenue of 97.36M SAR in the quarter ending March 31, 2025, with 28.41% growth. This brings the company's revenue in the last twelve months to 415.54M, up 15.74% year-over-year. In the year 2024, Middle East Pharmaceutical Industries Company had annual revenue of 394.00M with 16.42% growth.

Revenue (ttm)

415.54M

Revenue Growth

+15.74%

P/S Ratio

5.82

Revenue / Employee

657.50K

Employees

632

Market Cap

2.42B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	394.00M	55.56M	16.42%
Dec 31, 2023	338.44M	35.78M	11.82%
Dec 31, 2022	302.66M	15.44M	5.38%
Dec 31, 2021	287.22M	-14.44M	-4.79%
Dec 31, 2020	301.66M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Dr. Sulaiman Al Habib Medical Services Group Company	11.84B
Nahdi Medical Company	9.82B
Mouwasat Medical Services Company	2.92B
Dallah Healthcare Company	3.25B
Jamjoom Pharmaceuticals Factory Company	1.39B
Dr. Soliman Abdel Kader Fakeeh Hospital Company	2.81B
National Medical Care Company	1.38B
Almoosa Health Company	1.25B

Revenue Rankings